Brain Mapping Instruments
Brain diseases have been rising in various parts of the world. Parts of Europe, followed by Asian countries, have observed a growth towards the rise of brain-related health diseases.
For instance, a 2022 Delaware report depicts that market, which has been facing a rise in the proportion of the population aged 65, with an increase in dementia and Alzheimer’s. Moreover, as per the Alzheimer’s Association, it has been estimated that the population experiencing Alzheimer’s in the U.S. is likely to increase from 55 million to 88 million by the year 2050.
The data predicts a rise in the use of global brain mapping instruments. Addressing the matter, North America is likely to pay attention to the growth of brain mapping instruments globally, with an advanced adoption of new technology. Other countries such as China and Japan, with their dominance over technology, will also find a positive growth in the manufacture and use of brain mapping instruments.
With a driven growth in the use of brain mapping instruments, certain barriers still exist, such as their high costs, which are interrelated with the brain mapping process, followed by poor health insurance coverage.
Facing these barriers, a trend of rental contract agreement will prove useful, where the end-users could pay a certain amount for every brain mapping performed through brain mapping instruments. This would make it possible for diagnostic labs to conduct the procedure on low budgets without the need for capital investments.
